{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "9685243", "DateCompleted": {"Year": "1998", "Month": "08", "Day": "17"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0022-2623", "JournalIssue": {"Volume": "41", "Issue": "16", "PubDate": {"Year": "1998", "Month": "Jul", "Day": "30"}}, "Title": "Journal of medicinal chemistry", "ISOAbbreviation": "J Med Chem"}, "ArticleTitle": "A new approach to the design of novel inhibitors of Na+,K+-ATPase: 17alpha-substituted seco-D 5beta-androstane as cassaine analogues.", "Pagination": {"StartPage": "3033", "EndPage": "3040", "MedlinePgn": "3033-40"}, "Abstract": {"AbstractText": ["A new three-dimensional model for the relative binding mode of cassaine 1 and digitoxigenin 2 at the digitalis receptor site is proposed on the basis of the structural and conformational similarities among 1, 2 and its 14,15-seco analogues 3 and 4. Accordingly, the speculation that also 17alpha-substituted derivatives of the digitalis 5beta,14beta-androstane skeleton could efficiently bind to the Na+,K+-ATPase receptor is put forward and verified through the synthesis of some related compounds. The binding affinity shown by 2-(N,N-dimethylamino)ethyl 3beta, 14-dihydroxy-5beta,14beta-androstane-17alpha-acrylate 6 (IC50 = 5.89 microM) and, much more significantly, by the corresponding 14, 15-seco-14-oxo derivative 9 (IC50 = 0.12 microM) substantiates the new hypothesis and opens new prospects to the design of novel inhibitors of Na+,K+-ATPase as potential positive inotropic compounds."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departments of Medicinal Chemistry and Cellular Biology, Prassis Istituto di Ricerche Sigma-Tau, Via Forlanini 3, 20019 Settimo Milanese, Milano, Italy, and S.IN Soluzioni Informatiche, via Salvemini 9, 36100 Vicenza, Italy. mc340@mclink.it"}], "LastName": "De Munari", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Barassi", "ForeName": "P", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Cerri", "ForeName": "A", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Fedrizzi", "ForeName": "G", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Gobbini", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Mabilia", "ForeName": "M", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Melloni", "ForeName": "P", "Initials": "P"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Med Chem", "NlmUniqueID": "9716531", "ISSNLinking": "0022-2623"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Abietanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Alkaloids"}, {"RegistryNumber": "0", "NameOfSubstance": "Androstanes"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "digitalis receptor"}, {"RegistryNumber": "EC 7.2.2.13", "NameOfSubstance": "Sodium-Potassium-Exchanging ATPase"}, {"RegistryNumber": "PQK203C49T", "NameOfSubstance": "cassaine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Abietanes"}, {"QualifierName": ["chemistry", "metabolism"], "DescriptorName": "Alkaloids"}, {"QualifierName": ["chemical synthesis", "chemistry", "metabolism", "pharmacology"], "DescriptorName": "Androstanes"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Binding, Competitive"}, {"QualifierName": ["chemistry"], "DescriptorName": "Digitalis"}, {"QualifierName": [], "DescriptorName": "Dogs"}, {"QualifierName": [], "DescriptorName": "Drug Design"}, {"QualifierName": ["chemical synthesis", "chemistry", "metabolism", "pharmacology"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Kidney"}, {"QualifierName": [], "DescriptorName": "Models, Molecular"}, {"QualifierName": [], "DescriptorName": "Molecular Conformation"}, {"QualifierName": [], "DescriptorName": "Molecular Mimicry"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Plants, Toxic"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "metabolism"], "DescriptorName": "Sodium-Potassium-Exchanging ATPase"}, {"QualifierName": [], "DescriptorName": "Stereoisomerism"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "7", "Day": "31"}, {"Year": "1998", "Month": "7", "Day": "31", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "7", "Day": "31", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9685243", "10.1021/jm980108d", "jm980108d"]}}]}